haloperidol has been researched along with Central Nervous System Origin Vertigo in 2 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chouinard, G | 1 |
| Serrano, PM | 1 |
| Tetreault, L | 1 |
2 other studies available for haloperidol and Central Nervous System Origin Vertigo
| Article | Year |
|---|---|
Potentiation of haloperidol by -methyldopa in the treatment of schizophrenic patients.
Topics: Adult; Antiparkinson Agents; Basal Ganglia Diseases; Blood Pressure; Body Weight; Drug Synergism; Fe | 1973 |
Occupational health case report--no. 4. Epoxy-type paint.
Topics: Air; Animals; Chromatography, Gas; Dermatitis, Occupational; Environmental Exposure; Epoxy Resins; G | 1974 |